Pipeline

Drug candidateIndicationPre-clinicalPhase 1Phase 2Phase 3
SP1049CUpper GI cancer
Pre-Clinical - 100%
Phase I - 100%
Phase II - 100%
SPA
SP1049CNSCLC
Pre-clinical - 100%
Phase I - 100%
SP1049CColorectal cancer
Pre-Clinical - 100%
Phase I - 100%
SP1031CNHL
Pre-Clinical - 50%
SP1063CColorectal cancer
Pre-Clinical - 50%
SP1015CProstate cancer
Pre-Clinical - 50%
SP1012CBreast cancer
Pre-Clinical - 50%
SP1060C-OSCLC
Pre-Clinical - 50%
SP1060C-O Ovarian cancer
Pre-Clinical - 50%

View in: Mobile | Standard